Skip to main content
OpenTrials
Completed

NCT Number: NCT00002264

The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea

To examine the efficacy of cow's milk immune globulin in the treatment of diarrhea due to chronic intestinal cryptosporidiosis in patients with AIDS. The secondary end points of the study involve functional improvement which will be determined from nutritional and absorption studies.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients must have:

  • Diagnosis of diarrhea associated with intestinal cryptosporidiosis.

Exclusion criteria

Co-existing Condition:

Patients with the following conditions or symptoms are excluded:

  • Survival time projected to be < 9 weeks.
  • Inability to tolerate any oral intake.
  • Known allergy or intolerance to milk products.
  • Organic mental syndrome precluding informed consent or following directions.

Patients with the following are excluded:

  • Survival time projected to be < 9 weeks.
  • Inability to tolerate any oral intake.
  • Known allergy or intolerance to milk products.
  • Organic mental syndrome precluding informed consent or following directions.

Treatment and study plan

Cryptosporidium Immune Whey Protein Concentrate (Bovine)

Drug

Sponsors and collaborators

Lead sponsor

Stolle Milk Biologic International

Industry

Registry information

Official study title

Efficacy of Cow's Milk Immune Globulin in the Treatment of Chronic Intestinal Cryptosporidiosis in Patients With AIDS

Important dates

First posted
Aug 31, 2001
Registry last updated
Jun 24, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.